In the BioHarmony Drug Report Database
Losartan
Cozaar (losartan) is a small molecule pharmaceutical. Losartan was first approved as Cozaar on 1995-04-14. It is used to treat diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction, and left ventricular hypertrophy in the USA. The pharmaceutical is active against type-1 angiotensin II receptor. In addition, it is known to target cytochrome P450 2C9.
Trade Name
|
Cozaar |
|---|---|
Common Name
|
losartan |
ChEMBL ID
|
CHEMBL191 |
Indication
|
diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction, left ventricular hypertrophy |
Drug Class
|
Angiotensin II receptor antagonists |
Image (chem structure or protein)